|1||Active, not recruiting||
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
† Study has passed its completion date and status has not been verified in more than two years.